This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
European Drugs of Abuse Testing Market 2014: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Contains 300 pages and 48 tables
SIMILAR MARKET STUDIES
About This ReportThis new 322-page report from VPGMarketResearch.com presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals, Physician Offices, Commercial and ...
October 2015 | $2500 | View Details >>
2017 Hong Kong Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales ...
January 2017 | $0 | View Details >>
2014-2018 US Point-of-Care Infectious Disease Testing Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers-Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Strategies
2014-2018 US Point-of-Care Infectious Disease Testing Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers-Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Strategies. This new 795-page report from Venture Planning Group contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, ...
November 2014 | $3600 | View Details >>
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. Summary This comprehensive report contains 405 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the French coagulation testing market during the next five years. The ...
January 2014 | $3950 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research